# Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging

> **NCT02478138** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 1 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **PROCEDURE:** Sentinel lymph node mapping
- **DRUG:** Indocyanine Green (ICG)
- **DEVICE:** near-infrared fluorescence (NIR) imaging (Pinpoint, Novadaq, Waterloo)

## Key facts

- **NCT ID:** NCT02478138
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2024-01-08
- **Final completion:** 2024-01-08
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478138, "Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02478138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*